Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation

Parkinson's disease, bipolar disorder, and chronic pain targeted in study Study aims to support psilocybin as a potential therapeutic for inflammatory disorders

byBenzinga Newsdesk

January 10, 2023

1 minute read

Parkinson’s disease, bipolar disorder, and chronic pain targeted in study

Study aims to support psilocybin as a potential therapeutic for inflammatory disorders

Del Taco Signs New 10-Unit Franchise Development Agreement In Virginia Beach

By Benzinga Newsdesk

Today, 4:50 AM

Del Taco Restaurants, Inc. (NASDAQ:TACO), the nation's second largest Mexican quick service restaurant*, has signed a deal with successful franchisees Bharat Patel and Steve Kissel of Virginia Taco,

TACO

Goldman Sachs Initiates Coverage On Rent the Runway with Buy Rating, Announces Price Target of $25

By Benzinga Newsdesk

Today, 4:50 AM

Goldman Sachs analyst Eric Sheridan initiates coverage on Rent the Runway (NASDAQ:RENT) with a Buy rating and announces Price Target of $25.

RENT

CORRECTION: Enjoy Technology Q3 EPS $(0.83) Misses $(0.55) Estimate, Sales $18.59M Miss $28.45M Estimate

By Benzinga Newsdesk

Today, 4:50 AM

Enjoy Technology (NASDAQ:ENJY) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.55) by 50.91 percent. The company reported quarterly sales of $18.59 million which missed

ENJY

Mid-Day Market Update: Nasdaq Jumps 300 Points; Aurora Cannabis Shares Plunge

By Lisa Levin

Today, 4:50 AM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Friday.

ACB

Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation

Related Posts

Del Taco Signs New 10-Unit Franchise Development Agreement In Virginia Beach

Goldman Sachs Initiates Coverage On Rent the Runway with Buy Rating, Announces Price Target of $25

CORRECTION: Enjoy Technology Q3 EPS $(0.83) Misses $(0.55) Estimate, Sales $18.59M Miss $28.45M Estimate

Mid-Day Market Update: Nasdaq Jumps 300 Points; Aurora Cannabis Shares Plunge